516 related articles for article (PubMed ID: 33539847)
21. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
Church RJ; Watkins PB
Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of idiosyncratic drug-induced liver injury in children: results from the DILIN prospective study.
Molleston JP; Fontana RJ; Lopez MJ; Kleiner DE; Gu J; Chalasani N;
J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):182-9. PubMed ID: 21788760
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced liver injury at a tertiary care centre in Germany: Model for end-stage liver disease is the best predictor of outcome.
Reike-Kunze M; Zenouzi R; Hartel J; Krech T; Weidemann S; Sterneck M; Weiler-Normann C; Lohse AW; Schramm C; Sebode M
Liver Int; 2021 Oct; 41(10):2383-2395. PubMed ID: 34152686
[TBL] [Abstract][Full Text] [Related]
24. Amoxicillin-Clavulanate-Induced Liver Injury.
deLemos AS; Ghabril M; Rockey DC; Gu J; Barnhart HX; Fontana RJ; Kleiner DE; Bonkovsky HL;
Dig Dis Sci; 2016 Aug; 61(8):2406-2416. PubMed ID: 27003146
[TBL] [Abstract][Full Text] [Related]
25. Serious liver injury induced by Nimesulide: an international collaborative study.
Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
[TBL] [Abstract][Full Text] [Related]
26. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset.
Fontana RJ; Hayashi PH; Gu J; Reddy KR; Barnhart H; Watkins PB; Serrano J; Lee WM; Chalasani N; Stolz A; Davern T; Talwakar JA;
Gastroenterology; 2014 Jul; 147(1):96-108.e4. PubMed ID: 24681128
[TBL] [Abstract][Full Text] [Related]
27. ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
Chalasani NP; Maddur H; Russo MW; Wong RJ; Reddy KR;
Am J Gastroenterol; 2021 May; 116(5):878-898. PubMed ID: 33929376
[TBL] [Abstract][Full Text] [Related]
28. Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions.
Pinazo-Bandera JM; Niu H; Alvarez-Alvarez I; Medina-Cáliz I; Del Campo-Herrera E; Ortega-Alonso A; Robles-Díaz M; Hernández N; Paraná R; Nunes V; Girala M; Bessone F; Lucena MI; Andrade RJ; García Cortés M
Pharmacol Res; 2024 May; 203():107183. PubMed ID: 38631619
[TBL] [Abstract][Full Text] [Related]
29. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.
Bessone F; Ferrari A; Hernandez N; Mendizabal M; Ridruejo E; Zerega A; Tanno F; Reggiardo MV; Vorobioff J; Tanno H; Arrese M; Nunes V; Tagle M; Medina-Caliz I; Robles-Diaz M; Niu H; Alvarez-Alvarez I; Stephens C; Lucena MI; Andrade RJ
Arch Toxicol; 2023 Feb; 97(2):593-602. PubMed ID: 36416910
[TBL] [Abstract][Full Text] [Related]
30. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke R; Méndez-Sánchez N; Eickhoff A
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
[TBL] [Abstract][Full Text] [Related]
31. Elevated bilirubin, alkaline phosphatase at onset, and drug metabolism are associated with prolonged recovery from DILI.
Ashby K; Zhuang W; González-Jimenez A; Alvarez-Alvarez I; Lucena MI; Andrade RJ; Aithal GP; Suzuki A; Chen M
J Hepatol; 2021 Aug; 75(2):333-341. PubMed ID: 33845060
[TBL] [Abstract][Full Text] [Related]
32. The natural history of drug-induced liver injury.
Björnsson E
Semin Liver Dis; 2009 Nov; 29(4):357-63. PubMed ID: 19826969
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.
Bessone F; Hernandez N; Tagle M; Arrese M; Parana R; Méndez-Sánchez N; Ridruejo E; Mendizabal M; Dagher L; Contreras F; Fassio E; Pessoa M; Brahm J; Silva M
Ann Hepatol; 2021; 24():100321. PubMed ID: 33609753
[TBL] [Abstract][Full Text] [Related]
34. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
[TBL] [Abstract][Full Text] [Related]
35. Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids.
Robles-Diaz M; Gonzalez-Jimenez A; Medina-Caliz I; Stephens C; García-Cortes M; García-Muñoz B; Ortega-Alonso A; Blanco-Reina E; Gonzalez-Grande R; Jimenez-Perez M; Rendón P; Navarro JM; Gines P; Prieto M; Garcia-Eliz M; Bessone F; Brahm JR; Paraná R; Lucena MI; Andrade RJ; ;
Aliment Pharmacol Ther; 2015 Jan; 41(1):116-25. PubMed ID: 25394890
[TBL] [Abstract][Full Text] [Related]
36. The diagnosis and management of idiosyncratic drug-induced liver injury.
Hassan A; Fontana RJ
Liver Int; 2019 Jan; 39(1):31-41. PubMed ID: 30003672
[TBL] [Abstract][Full Text] [Related]
37. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
[TBL] [Abstract][Full Text] [Related]
38. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
Xu HM; Chen Y; Xu J; Zhou Q
World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
[TBL] [Abstract][Full Text] [Related]
39. Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.
Radovanovic M; Dushenkovska T; Cvorovic I; Radovanovic N; Ramasamy V; Milosavljevic K; Surla J; Jecmenica M; Radulovic M; Milovanovic T; Dumic I
Am J Case Rep; 2018 Sep; 19():1152-1161. PubMed ID: 30266895
[TBL] [Abstract][Full Text] [Related]
40. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]